ATP7B Antibodies

Santa Cruz Biotechnology provides a broad selection of ATP7B monoclonal antibodies for research focused on understanding ATP7B protein function. ATP7B monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ATP7B, also known as Wilson's disease protein, plays a vital role in copper transport and homeostasis in the body. Mutations in the ATP7B gene can lead to Wilson's disease, a genetic disorder that results in copper accumulation and toxicity, affecting the liver and brain. Understanding ATP7B function is essential for developing therapeutic strategies for related disorders and advancing knowledge of metal ion metabolism. ATP7B monoclonal antibodies enable precise detection and analysis of ATP7B expression patterns across different tissues and cellular compartments. Researchers can investigate ATP7B localization, protein-protein interactions, and regulatory mechanisms using multiple experimental approaches. ATP7B monoclonal antibodies from Santa Cruz Biotechnology support cutting-edge research that advances our understanding of copper transport disorders and potential therapeutic interventions.